N-Nitroso Nortriptyline D3 | N-Nitroso Amitriptyline EP Impurity C-D3
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. N-Nitroso Nortriptyline D3can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines . N-Nitroso Nortriptyline D3 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline D3 CAS NO:NA is also known as N-Nitroso Amitriptyline EP Impurity C-D3 Chemically represented as N-(3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)-N-(methyl-d3)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline D3. We supply N-Nitroso Nortriptyline D3 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143953 |
| CAS No | NA |
| Mol.F. | C8H19N5O |
| Mol.Wt. | 201.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143954 |
| CAS No | NA |
| Mol.F. | C2H3N5O |
| Mol.Wt. | 113.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143955 |
| CAS No | NA |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143956 |
| CAS No | 139615-59-1 |
| Mol.F. | C3H6N2O |
| Mol.Wt. | 86.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143957 |
| CAS No | 36147-29-2 |
| Mol.F. | C3HN3O |
| Mol.Wt. | 95.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143958 |
| CAS No | NA |
| Mol.F. | C9H16N2O4 |
| Mol.Wt. | 216.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143959 |
| CAS No | 61467-70-7 |
| Mol.F. | C5H10N2O2 |
| Mol.Wt. | 130.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143960 |
| CAS No | 89614-31-3 |
| Mol.F. | C5H11N3O2 |
| Mol.Wt. | 145.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143961 |
| CAS No | NA |
| Mol.F. | C22H17FN6O3 |
| Mol.Wt. | 432.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143962 |
| CAS No | NA |
| Mol.F. | C11H17N5O : 2(HBr) |
| Mol.Wt. | 235.3 : 2(80.9) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143963 |
| CAS No | NA |
| Mol.F. | C11H17N5O : 2(HBr) |
| Mol.Wt. | 235.3 : 2(80.9) g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143964 |
| CAS No | NA |
| Mol.F. | C2H5N3O2 |
| Mol.Wt. | 103.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143965 |
| CAS No | NA |
| Mol.F. | C9H11N3O |
| Mol.Wt. | 177.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143966 |
| CAS No | NA |
| Mol.F. | C5H7D5N2O |
| Mol.Wt. | 121.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143967 |
| CAS No | NA |
| Mol.F. | C5H10N2O3 |
| Mol.Wt. | 146.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143968 |
| CAS No | NA |
| Mol.F. | C7H14N4O |
| Mol.Wt. | 170.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |